Novartis India Ltd. - Research Center
500672 NOVARTIND Group (B) BSE data
Add to watchlist
| Results | |
| Statement |
Cash flow
|
| More |
Cash flow
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Profit before tax | 122.84 | 115.38 | -3.82 | 40.04 | 28.64 |
| Net cashflow-operating activity | 113.40 | 44.80 | 38.67 | -69.21 | -23.14 |
| Net cash used in investing activity | 33.13 | -153.25 | 87.04 | 95.16 | 55.91 |
| Netcash used in fin. activity | -120.99 | -30.48 | -35.63 | -36.80 | -41.41 |
| Net inc/dec in cash and equivlnt | 25.54 | -138.93 | 90.08 | -10.85 | -8.64 |
| Cash and equivalnt begin of year | 19.42 | 158.35 | 68.27 | 79.12 | 87.76 |
| Cash and equivalnt end of year | 44.96 | 19.42 | 158.35 | 68.27 | 79.12 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis